Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
about
Purinergic signalling and cancerTwo subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cellsPharmacological characterization of the human P2Y11 receptorP2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinaseThe C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptorAn examination of deoxyadenosine 5'(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptorSecond messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptorMolecular recognition in P2 receptors: ligand development aided by molecular modeling and mutagenesis.Pharmacochemistry of the platelet purinergic receptors.ADP-evoked phospholipase C stimulation and adenylyl cyclase inhibition in glioma C6 cells occur through two distinct nucleotide receptors, P2Y(1) and P2Y(12).Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.Drug analysis based on signaling responses to G-protein-coupled receptors.Purinoceptor subtypes mediating contraction and relaxation of marmoset urinary bladder smooth muscleModulation of extracellular GABA levels in the retina by activation of glial P2X-purinoceptors.Nucleotide-mediated relaxation in guinea-pig aorta: selective inhibition by MRS2179.Differential effects of P2Y1 and P2Y12 nucleotide receptors on ERK1/ERK2 and phosphatidylinositol 3-kinase signalling and cell proliferation in serum-deprived and nonstarved glioma C6 cellsDevelopment of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor.Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive ratsQuantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist.Pannexin 3 functions as an ER Ca(2+) channel, hemichannel, and gap junction to promote osteoblast differentiation.Potent agonist action of 2-thioether derivatives of adenine nucleotides at adenylyl cyclase-linked P2Y-purinoceptors.Identification of potent P2Y-purinoceptor agonists that are derivatives of adenosine 5'-monophosphate.Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophagesSynthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor AntagonistsA mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor.Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.Evidence for the Recognition of Non-Nucleotide Antagonists Within the Transmembrane Domains of the Human P2Y(1) ReceptorActions of a Series of PPADS Analogs at P2X1 and P2X3 ReceptorsNeuroprotective roles of the P2Y(2) receptor.Paracrine mediation of calcium signaling in human SK-N-MCIXC neuroepithelioma cells.Novel consequences of voltage-dependence to G-protein-coupled P2Y1 receptors.Adenosine triphosphate inhibits melatonin synthesis in the rat pineal gland.P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells.P2 receptors are involved in the mediation of motivation-related behavior.Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C.The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclasePPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors.Purinoceptors: from history to recent progress. A review.Design and pharmacology of selective P2-purinoceptor antagonists.Nucleotide receptors in the nervous system. An abundant component using diverse transduction mechanisms.
P2860
Q24618782-4AD04D0B-9B1D-4FED-982E-173819D0E539Q24674148-4A7AE0C9-B47E-4D65-A8BD-D2CDDB2427C0Q28343735-C550FE54-99B9-4307-82C7-6337E78FB4C9Q28359340-5EDC433B-64E6-4438-9264-F3837E357C54Q28366572-FECE6091-84A1-4703-A617-56C7AAF4E631Q28378930-E4100ABD-3F5B-4B4B-AA65-893C0D0C1928Q28637757-B1FAFD50-0295-48C4-A078-47D7E2581FC8Q33768388-24CA6BBC-55C9-48BE-8710-D954F8B3D43BQ33869922-DDB12762-FDD1-4CD4-BDA0-A6938D60ECF3Q34119498-CDD2F73F-4D57-4E49-87E9-E95B9DDFDECEQ34453608-055D804D-D2D4-4FB3-820C-E46D95F6CDC7Q34470781-0C86A1D1-E5DF-4D5C-B1EA-6FF5B98CC3A5Q35027442-C27B6038-D718-412E-9D71-5B2200EAF123Q35027584-4E7FB726-A572-4A3F-B449-E3BF8B59CD06Q35044028-094B604B-B679-4066-B194-74323E8E94ECQ35046114-8AC85946-307F-42B1-AF25-7430DA492B45Q35050462-FF6F91B3-FD55-45B8-9149-5C431E340078Q35057133-286F12ED-3C66-4965-8FDD-DB571DD067CEQ35200801-B0858AD8-852B-4D78-9986-1D73F600E6B0Q35550768-CEE954E6-4D9A-4403-B4DE-F6D90BFC6AD0Q35873053-E6AA3EFD-4D96-41B9-AB40-9A5521B23214Q35874099-CBE8D179-9D90-4E73-A90F-D107295A8247Q35884598-18D44C88-C4F1-4BE0-9F0C-A438A5B19F7FQ36178575-D6810ED1-B3E0-4324-8314-4BC341F66365Q36183040-D701133F-A482-473D-9D1F-6F509A009DBFQ36282943-BBF9FF3D-0CB8-4706-A427-5CF56FC01C87Q36343279-043553E7-29A4-48D4-9D52-243011602940Q36852764-3208A1DC-6D05-4287-83A9-2BD516E10690Q38005033-F3E51CD9-BA20-4BEB-9C52-DE4CA85DC8DDQ39427868-17167477-2F37-4390-BD9A-AA31BDF09667Q39572678-4AB19DDE-BDEC-4C2A-B1F9-9386E9A8B3CAQ40144035-67C1FAC9-98A3-4F2E-B10A-51C384F18E35Q40631402-58F56138-BF04-4A18-BACB-378579BD5F4CQ40723755-29507293-2A48-4109-A2BB-807683225341Q41076342-1BBC69D6-0534-4452-BE85-5C4C8477E00EQ41148501-85A1B9B2-E98E-48D4-89AD-BAD36E6727E7Q41194842-2E9CE25B-0348-4F94-8F20-1C9FFAB6C4CCQ41255014-0C33B092-8AF2-4E5E-AEB0-26F0CE85AF0EQ41455996-EAA9BF1E-2B78-4D21-8EEE-7AC87A4850C4Q41659783-3CA9B75C-A87C-4DD1-8C54-E2562536964C
P2860
Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Differential effects of P2-pur ...... ase-coupled P2Y-purinoceptors.
@ast
Differential effects of P2-pur ...... ase-coupled P2Y-purinoceptors.
@en
Differential effects of P2-pur ...... ase-coupled P2Y-purinoceptors.
@nl
type
label
Differential effects of P2-pur ...... ase-coupled P2Y-purinoceptors.
@ast
Differential effects of P2-pur ...... ase-coupled P2Y-purinoceptors.
@en
Differential effects of P2-pur ...... ase-coupled P2Y-purinoceptors.
@nl
prefLabel
Differential effects of P2-pur ...... ase-coupled P2Y-purinoceptors.
@ast
Differential effects of P2-pur ...... ase-coupled P2Y-purinoceptors.
@en
Differential effects of P2-pur ...... ase-coupled P2Y-purinoceptors.
@nl
P2093
P2860
P1476
Differential effects of P2-pur ...... ase-coupled P2Y-purinoceptors.
@en
P2093
K A Jacobson
T K Harden
P2860
P304
P356
10.1111/J.1476-5381.1994.TB17034.X
P407
P577
1994-10-01T00:00:00Z